Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Ticker SymbolEMBC
Company nameEmbecta Corp
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)
Number of employees1850
Security typeOrdinary Share
Fiscal year-endMar 21
Address300 Kimball Drive
CityPARSIPPANY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07054
Phone18624010000
Websitehttps://www.embecta.com/
Ticker SymbolEMBC
IPO dateMar 21, 2022
CEOKurdikar (Devdatt)